McLaughlin J - Search Results

1

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.

Laframboise S, Chapman W, McLaughlin J, Andrulis IL. Laframboise S, et al. Among authors: mclaughlin j. Cancer J. 2000 Sep-Oct;6(5):302-8. Cancer J. 2000. PMID: 11079169

2

Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results.

McLaughlin J, Gladman DD, Urowitz MB, Bombardier C, Farewell VT, Cole E. McLaughlin J, et al. Arthritis Rheum. 1991 Oct;34(10):1268-73. doi: 10.1002/art.1780341010. Arthritis Rheum. 1991. PMID: 1930316

3

Repeatability of interview-derived information on sexual history: a study in women.

Rohan TE, McLaughlin JR, Harnish DG. Rohan TE, et al. Among authors: mclaughlin jr. Epidemiology. 1994 May;5(3):360-3. doi: 10.1097/00001648-199405000-00019. Epidemiology. 1994. PMID: 8038255

4

Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables.

McLaughlin JR, Bombardier C, Farewell VT, Gladman DD, Urowitz MB. McLaughlin JR, et al. Arthritis Rheum. 1994 Apr;37(4):559-67. doi: 10.1002/art.1780370417. Arthritis Rheum. 1994. PMID: 8147934

5

An historical cohort study of cardiac catheterization during childhood and the risk of cancer.

McLaughlin JR, Kreiger N, Sloan MP, Benson LN, Hilditch S, Clarke EA. McLaughlin JR, et al. Int J Epidemiol. 1993 Aug;22(4):584-91. doi: 10.1093/ije/22.4.584. Int J Epidemiol. 1993. PMID: 8225729

6

CDKN2A mutations in multiple primary melanomas.

Monzon J, Liu L, Brill H, Goldstein AM, Tucker MA, From L, McLaughlin J, Hogg D, Lassam NJ. Monzon J, et al. Among authors: mclaughlin j. N Engl J Med. 1998 Mar 26;338(13):879-87. doi: 10.1056/NEJM199803263381305. N Engl J Med. 1998. PMID: 9516223

7

p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Casson AG, Tammemagi M, Eskandarian S, Redston M, McLaughlin J, Ozcelik H. Casson AG, et al. Among authors: mclaughlin j. Mol Pathol. 1998 Apr;51(2):71-9. doi: 10.1136/mp.51.2.71. Mol Pathol. 1998. PMID: 9713589 Free PMC article.

8

Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers.

Tammemagi MC, McLaughlin JR, Bull SB. Tammemagi MC, et al. Among authors: mclaughlin jr. Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):625-34. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10428201

9

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ. Zweemer RP, et al. Among authors: mclaughlin jr. J Clin Pathol. 1999 May;52(5):372-5. doi: 10.1136/jcp.52.5.372. J Clin Pathol. 1999. PMID: 10560359 Free PMC article.

10

Premorbid diet in relation to survival from prostate cancer (Canada).

Kim DJ, Gallagher RP, Hislop TG, Holowaty EJ, Howe GR, Jain M, McLaughlin JR, Teh CZ, Rohan TE. Kim DJ, et al. Among authors: mclaughlin jr. Cancer Causes Control. 2000 Jan;11(1):65-77. doi: 10.1023/a:1008913620344. Cancer Causes Control. 2000. PMID: 10680731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results